Online Motor-Cognitive Testing to Detect Early Signs of Alzheimers Disease in Adults Over 50
Led by University of Tasmania · Updated on 2023-10-30
3000
Participants Needed
1
Research Sites
260 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating a new online motor-cognitive test called the TAS Test to detect early signs of Alzheimers disease AD before cognitive symptoms appear. AD usually develops silently over 10-20 years during a preclinical phase, and early detection is important to offer interventions before irreversible brain damage occurs. This observational study aims to create a scalable, non-invasive test that people can take from home using their computers, combining hand-movement analysis with cognitive assessments and blood biomarkers.
The study consists of two parts Sub-study 1 will recruit 500 participants over 50 years old with normal cognition from existing cohorts to complete the TAS Test online or in a research center at baseline, 3 months, and 6 months. Blood samples will measure a biomarker called p-tau181. Sub-study 2 will involve 10,000 adults who will complete the TAS Test every 6 months and cognitive tests every 24 months at home over 5 years. The researchers will use the data to develop an algorithm that predicts risk of cognitive decline and Alzheimers disease.
Participants will complete online motor and cognitive tests from home, with some visits for blood tests and clinical diagnosis in a smaller group. The study will monitor changes in hand movements, cognitive scores, and blood markers over time to validate the TAS Tests ability to predict Alzheimers risk. The research includes follow-up over 3 to 5 years to assess cognitive decline and diagnosis outcomes, providing a comprehensive evaluation of this new testing approach.
CONDITIONS
Brief Title
TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease
Research Team
A
A/Prof Alty, MD FRACP
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
National Health and Medical Research Council, Australia
Collaborating Sponsor
Who Can Participate
Age: 50Years +
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Age 50 years or older
You will not qualify if you...
Established diagnosis of dementia
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for eligibility confirmation and baseline blood test
Diagnostic Evaluation
Duration - Baseline visit plus 6 months
Participants complete online motor-cognitive tests and have baseline blood biomarker assessments to evaluate cognitive status and detect pre-Alzheimer's disease changes.
3 visits (baseline, 3 months, and 6 months) completed online or at the research centre
Long-term Monitoring
Duration - Up to 5 years
Participants complete online motor-cognitive tests every 6 months and undergo cognitive assessments every 24 months to monitor changes over time and validate risk predictions.
Online visits every 6 months for TAS Test and every 24 months for CANTAB assessments
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
100-Year Human Aging Study Long-Term Follow-Up of Multi-System Health Measures to Predict Mortality and Aging Outcomes
Trial of the 5-Cog Assessment to Detect Cognitive Impairment and Improve Dementia Care in Older Adults with Cognitive Concerns in Primary Care
Comparing Cardiac 18F-MFBG PET and 123I-MIBG SPECT to Differentiate Parkinsons Disease, Multiple System Atrophy, Dementia with Lewy Bodies, and Alzheimers Disease
Phase 3 Study of PET Imaging With 18FPI-2620 to Detect Tau Protein in Alzheimers Disease Compared to Brain Autopsy
Using a Digital Life Story Application to Support Person-Centered Care for Older Adults with Dementia Healthcare Professionals Views
Feasibility Study of the Green Activity Program to Support People 45 and Older with Memory Challenges and Their Study Partners
Safety and Effects of LY3954068 Delivered into Spinal Fluid in Adults 50 to 85 Years Old With Early Alzheimers Disease
Study on How Gut Microbiome Affects Brain Health in Alzheimers Disease from Normal Cognition to Dementia
Multidomain Lifestyle Intervention to Prevent Cognitive Decline in Older Adults at Risk in Zhejiang, China
Combination of Sleep Promotion and Cognitive Training to Improve Brain Function in Older Adults After ICU Stay
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer's disease and estimate 5-year risks of cognitive decline and dementia.